Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 30, 2019 Off

Autism – Pipeline Review, H1 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Autism – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical and…

April 29, 2019 Off

White Paper: Safety Profile of the Analgesic Trezix™ Capsules, Containing the Mild Opioid Dihydrocodeine

By BusinessWire

RIDGELAND, Miss.–(BUSINESS WIRE)–Wraser Pharmaceuticals, a privately held pharmaceutical company announces the publication of a White Paper addressing opioid safety. Sharp…

April 29, 2019 Off

Pharma Clinical Trial Digitization – Companies to Action 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pharma Clinical Trial Digitization – Companies to Action, 2019” report has been added to ResearchAndMarkets.com’s offering. Despite the…

April 29, 2019 Off

Magenta Therapeutics Launches Proposed Public Offering

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of…

Medpace Holdings, Inc. Reports First Quarter 2019 Results
April 29, 2019 Off

Medpace Holdings, Inc. Reports First Quarter 2019 Results

By BusinessWire

Revenue of $200.7 million in the first quarter of 2019 increased 23.1% from revenue of $163.1 million for the comparable…

GlycoMimetics Bolsters Executive Team with Appointment of Dr. Eric Feldman as Vice President, Clinical Development, and Christian Dinneen-Long as Vice President, Corporate Counsel
April 29, 2019 Off

GlycoMimetics Bolsters Executive Team with Appointment of Dr. Eric Feldman as Vice President, Clinical Development, and Christian Dinneen-Long as Vice President, Corporate Counsel

By BusinessWire

Eric Feldman, M.D.,a specialist in leukemia and bone marrow disorder therapies, has beenappointed Vice President of Clinical Development GlycoMimetics.

Beam Therapeutics Presents Data on Multiplex Base Editing for Engineered CAR-T Cells at American Society of Gene and Cell Therapy 22nd Annual Meeting
April 29, 2019 Off

Beam Therapeutics Presents Data on Multiplex Base Editing for Engineered CAR-T Cells at American Society of Gene and Cell Therapy 22nd Annual Meeting

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the presentation of preclinical…

April 29, 2019 Off

RadianceTx® Expands Team to Develop Beta Ophthalmic System

By BusinessWire

TUCSON, Ariz. & LONDON–(BUSINESS WIRE)–Radiance Therapeutics, Inc. (RadianceTx®) is pleased to announce the expansion of its core team: Abigail Mackrill,…

April 29, 2019 Off

Eyenuk’s AI Eye Screening System For Diabetic Retinopathy Demonstrates Exceptional Performance In A Prospective, Multi-Center, Pivotal Clinical Trial

By BusinessWire

Investigators Report the EyeArt System Achieved 95.5% Sensitivity, 86.5% Specificity and 97% Imageability, while Meeting All Primary Endpoints with p<0.0001…

April 29, 2019 Off

The Global Pharmaceutical Contract Research & Manufacturing (CRAM) Market 2019-2023 – Projected to Register a CAGR of More Than 9% – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The pharmaceutical…

Posts pagination

Previous 1 … 3,244 3,245 3,246 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine